Baillie Gifford Health Innovation Equities Fund MRNA Holdings History
Baillie Gifford Health Innovation Equities Fund's Moderna Inc Holding Summary
As of 2024-09-30, Baillie Gifford Health Innovation Equities Fund held 3,837.00 shares of Moderna Inc(MRNA), totaling $256,430.00. This investment constitutes 3.76% of their stock portfolio, and Baillie Gifford Health Innovation Equities Fund now holds 0% of the outstanding Moderna Inc(MRNA) stock.
The initial trade took place in 2022Q1. And since then Baillie Gifford Health Innovation Equities Fund has made 6 purchases of MRNA, at an average price of $162.18, for a total of 11,162.00 shares. In addition, there have been 3 sales at an average price of $95.50 for 7,325.00 shares. Based on historical transaction data and MRNA's current price of $35.13, Baillie Gifford Health Innovation Equities Fund's estimated gain on his MRNA holdings is $-975,955.80, reflecting a -53.91% gain to date.
Baillie Gifford Health Innovation Equities Fund MRNA ($35.13) Holding Chart
Baillie Gifford Health Innovation Equities Fund MRNA ($35.13) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
